Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Patient perspectives on a treatment plan and summary program in community oncology care
    Meeting Abstract

    Blinder, V. S.; Norris, V. W.; Peacock, N. W.; Griggs, J. J.; Harrington, D. P.; Moore, A.; Theriault, R. L.; Partridge, A. H.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • TBCRC 018: Phase II study of iniparib plus chemotherapy to treat triple- negative breast cancer (TNBC) brain metastases (BM)
    Meeting Abstract

    Anders, C. K.; Nanda, R.; Liu, M. C.; Blackwell, K. L.; Van Poznak, C. H.; Abramson, V. G.; Storniolo, A. M.; Lin, N. U.; Stearns, V.; Melhem, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Quality of life in patients with advanced gastroesophageal (GE) adenocarcinoma treated with modified docetaxel, cisplatin, and fluorouracil (mDCF)
    Meeting Abstract

    Smyth, E. C.; Janjigian, Y. Y.; Robinson, E.; Sheehy, E. C.; Karpenko, I.; Capanu, M.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • mTOR kinase inhibition relieves feedback inhibition of RTK and PI3K signaling in breast cancer cells
    Meeting Abstract

    Rodrik-Outmezguine, V. S.; Chandarlapaty, S.; Cao, N.; Smith, P.; Guichard, S.; Rosen, N.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • MEK inhibitors prevent rebound reactivation of ERK signaling by the RAF inhibitor PLX4032 and enhance its antitumor activity
    Meeting Abstract

    Pratilas, C. A.; Joseph, E. W.; Tadi, M.; Gabay, M.; Wong, W.; De Stanchina, E.; Bollag, G.; Rosen, N.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • STAT3 signaling in thyroid cancer
    Meeting Abstract

    Silva, J.; Soares, P.; Knauf, J.; Fagin, J.; Sobrinho-Simoes, M.; Ghossein, R.; Bromberg, J. F.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Can PI3K/AKT pathway mutations predict for type of recurrence after conservative treatment for DCIS
    Meeting Abstract

    Sakr, R. A.; Andrade, V. P.; Muhsen, S.; Chandarlapaty, S.; Giri, D.; Olvera, N.; Paik, W.; Goldberg, J. I.; Van Zee, K. J.; Rosen, N.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • A model of tumor dormancy in Luminal A breast cancer
    Meeting Abstract

    Sansone, P.; Shapiro, L.; Chang, Q.; Berishaj, M.; Bromberg, J.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Effects of high-dose radiotherapy on the bone marrow microenvironment in the 4T1 model of breast cancer
    Meeting Abstract

    Shapiro, L. Q.; Sansone, P.; Granitto, S.; Lyden, D.; Bromberg, J.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • An in-frame deletion in the N-terminal regulatory domain of BRAF(V600E) causes resistance to the RAF inhibitor PLX4032
    Meeting Abstract

    Poulikakos, P. I.; Persaud, Y.; Gabay, M. T.; Janakiraman, M.; Joseph, E. W.; Pratilas, C. A.; Chapman, P. B.; Rosen, N.; Solit, D. B.
    Cancer Research (2011)

    Fulltext@MSK | Save